nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP1A1—Clobetasol propionate—psoriasis	0.118	0.175	CbGbCtD
Clonidine—CYP1A1—Methoxsalen—psoriasis	0.0622	0.0918	CbGbCtD
Clonidine—CYP3A5—Beclomethasone—psoriasis	0.0539	0.0795	CbGbCtD
Clonidine—CYP1A2—Clobetasol propionate—psoriasis	0.0529	0.0781	CbGbCtD
Clonidine—CYP1A1—Cholecalciferol—psoriasis	0.0412	0.0608	CbGbCtD
Clonidine—CYP1A2—Methoxsalen—psoriasis	0.0278	0.041	CbGbCtD
Clonidine—CYP2D6—Hydroxyurea—psoriasis	0.025	0.0369	CbGbCtD
Clonidine—CYP3A5—Mycophenolate mofetil—psoriasis	0.0215	0.0316	CbGbCtD
Clonidine—CYP3A4—Calcitriol—psoriasis	0.0187	0.0276	CbGbCtD
Clonidine—CYP1A1—Dexamethasone—psoriasis	0.0178	0.0263	CbGbCtD
Clonidine—CYP3A5—Hydrocortisone—psoriasis	0.0172	0.0254	CbGbCtD
Clonidine—CYP3A5—Cyclosporine—psoriasis	0.0163	0.024	CbGbCtD
Clonidine—CYP2D6—Cholecalciferol—psoriasis	0.0152	0.0224	CbGbCtD
Clonidine—CYP3A4—Methoxsalen—psoriasis	0.0146	0.0215	CbGbCtD
Clonidine—ABCB1—Mycophenolate mofetil—psoriasis	0.014	0.0206	CbGbCtD
Clonidine—ABCB1—Betamethasone—psoriasis	0.012	0.0177	CbGbCtD
Clonidine—ABCB1—Prednisolone—psoriasis	0.0118	0.0174	CbGbCtD
Clonidine—ABCB1—Hydrocortisone—psoriasis	0.0112	0.0165	CbGbCtD
Clonidine—ABCB1—Prednisone—psoriasis	0.0112	0.0165	CbGbCtD
Clonidine—CYP3A5—Dexamethasone—psoriasis	0.0107	0.0158	CbGbCtD
Clonidine—ABCB1—Cyclosporine—psoriasis	0.0106	0.0156	CbGbCtD
Clonidine—CYP2D6—Cyclosporine—psoriasis	0.00997	0.0147	CbGbCtD
Clonidine—CYP3A4—Cholecalciferol—psoriasis	0.00965	0.0142	CbGbCtD
Clonidine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00836	0.0123	CbGbCtD
Clonidine—CYP3A4—Triamcinolone—psoriasis	0.00836	0.0123	CbGbCtD
Clonidine—CYP3A4—Betamethasone—psoriasis	0.00718	0.0106	CbGbCtD
Clonidine—CYP3A4—Prednisolone—psoriasis	0.00708	0.0104	CbGbCtD
Clonidine—ABCB1—Dexamethasone—psoriasis	0.00697	0.0103	CbGbCtD
Clonidine—CYP3A4—Hydrocortisone—psoriasis	0.00671	0.0099	CbGbCtD
Clonidine—CYP3A4—Prednisone—psoriasis	0.00669	0.00987	CbGbCtD
Clonidine—CYP2D6—Dexamethasone—psoriasis	0.00657	0.00969	CbGbCtD
Clonidine—CYP3A4—Cyclosporine—psoriasis	0.00634	0.00935	CbGbCtD
Clonidine—ABCB1—Methotrexate—psoriasis	0.0056	0.00826	CbGbCtD
Clonidine—CYP3A4—Dexamethasone—psoriasis	0.00417	0.00616	CbGbCtD
Clonidine—Diclofenac—CXCL8—psoriasis	0.00111	1	CrCbGaD
Clonidine—Hypotension—Hydrocortisone—psoriasis	9.69e-05	0.000322	CcSEcCtD
Clonidine—Feeling abnormal—Cyclosporine—psoriasis	9.62e-05	0.000319	CcSEcCtD
Clonidine—Shock—Triamcinolone—psoriasis	9.61e-05	0.000319	CcSEcCtD
Clonidine—Insomnia—Prednisolone—psoriasis	9.6e-05	0.000319	CcSEcCtD
Clonidine—Alopecia—Prednisone—psoriasis	9.6e-05	0.000319	CcSEcCtD
Clonidine—Gastrointestinal pain—Cyclosporine—psoriasis	9.54e-05	0.000317	CcSEcCtD
Clonidine—Loss of consciousness—Betamethasone—psoriasis	9.54e-05	0.000317	CcSEcCtD
Clonidine—Loss of consciousness—Dexamethasone—psoriasis	9.54e-05	0.000317	CcSEcCtD
Clonidine—Dizziness—Mycophenolic acid—psoriasis	9.54e-05	0.000317	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—psoriasis	9.54e-05	0.000317	CcSEcCtD
Clonidine—Paraesthesia—Prednisolone—psoriasis	9.54e-05	0.000317	CcSEcCtD
Clonidine—Tachycardia—Triamcinolone—psoriasis	9.53e-05	0.000317	CcSEcCtD
Clonidine—Mental disorder—Prednisone—psoriasis	9.52e-05	0.000316	CcSEcCtD
Clonidine—Erythema—Prednisone—psoriasis	9.45e-05	0.000314	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.45e-05	0.000314	CcSEcCtD
Clonidine—Hyperhidrosis—Triamcinolone—psoriasis	9.44e-05	0.000314	CcSEcCtD
Clonidine—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.38e-05	0.000312	CcSEcCtD
Clonidine—Insomnia—Hydrocortisone—psoriasis	9.38e-05	0.000312	CcSEcCtD
Clonidine—Paraesthesia—Hydrocortisone—psoriasis	9.31e-05	0.000309	CcSEcCtD
Clonidine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.31e-05	0.000309	CcSEcCtD
Clonidine—Urticaria—Cyclosporine—psoriasis	9.27e-05	0.000308	CcSEcCtD
Clonidine—Abdominal pain—Cyclosporine—psoriasis	9.22e-05	0.000306	CcSEcCtD
Clonidine—Body temperature increased—Cyclosporine—psoriasis	9.22e-05	0.000306	CcSEcCtD
Clonidine—Anxiety—Dexamethasone—psoriasis	9.21e-05	0.000306	CcSEcCtD
Clonidine—Anxiety—Betamethasone—psoriasis	9.21e-05	0.000306	CcSEcCtD
Clonidine—Vomiting—Mycophenolic acid—psoriasis	9.17e-05	0.000305	CcSEcCtD
Clonidine—Discomfort—Dexamethasone—psoriasis	9.13e-05	0.000303	CcSEcCtD
Clonidine—Discomfort—Betamethasone—psoriasis	9.13e-05	0.000303	CcSEcCtD
Clonidine—Rash—Mycophenolic acid—psoriasis	9.09e-05	0.000302	CcSEcCtD
Clonidine—Dermatitis—Mycophenolic acid—psoriasis	9.09e-05	0.000302	CcSEcCtD
Clonidine—Pain—Prednisolone—psoriasis	9.08e-05	0.000302	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—psoriasis	9.08e-05	0.000301	CcSEcCtD
Clonidine—Urticaria—Mycophenolate mofetil—psoriasis	9.04e-05	0.0003	CcSEcCtD
Clonidine—Headache—Mycophenolic acid—psoriasis	9.04e-05	0.0003	CcSEcCtD
Clonidine—Decreased appetite—Hydrocortisone—psoriasis	9.02e-05	0.000299	CcSEcCtD
Clonidine—Body temperature increased—Mycophenolate mofetil—psoriasis	9e-05	0.000299	CcSEcCtD
Clonidine—Abdominal pain—Mycophenolate mofetil—psoriasis	9e-05	0.000299	CcSEcCtD
Clonidine—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.95e-05	0.000297	CcSEcCtD
Clonidine—Fatigue—Hydrocortisone—psoriasis	8.94e-05	0.000297	CcSEcCtD
Clonidine—Vision blurred—Prednisone—psoriasis	8.91e-05	0.000296	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.9e-05	0.000295	CcSEcCtD
Clonidine—Pain—Hydrocortisone—psoriasis	8.87e-05	0.000295	CcSEcCtD
Clonidine—Oedema—Betamethasone—psoriasis	8.86e-05	0.000294	CcSEcCtD
Clonidine—Oedema—Dexamethasone—psoriasis	8.86e-05	0.000294	CcSEcCtD
Clonidine—Insomnia—Triamcinolone—psoriasis	8.83e-05	0.000293	CcSEcCtD
Clonidine—Infection—Betamethasone—psoriasis	8.8e-05	0.000292	CcSEcCtD
Clonidine—Infection—Dexamethasone—psoriasis	8.8e-05	0.000292	CcSEcCtD
Clonidine—Ill-defined disorder—Prednisone—psoriasis	8.77e-05	0.000291	CcSEcCtD
Clonidine—Paraesthesia—Triamcinolone—psoriasis	8.77e-05	0.000291	CcSEcCtD
Clonidine—Feeling abnormal—Prednisolone—psoriasis	8.75e-05	0.000291	CcSEcCtD
Clonidine—Shock—Dexamethasone—psoriasis	8.72e-05	0.00029	CcSEcCtD
Clonidine—Shock—Betamethasone—psoriasis	8.72e-05	0.00029	CcSEcCtD
Clonidine—Dyspnoea—Triamcinolone—psoriasis	8.71e-05	0.000289	CcSEcCtD
Clonidine—Nervous system disorder—Dexamethasone—psoriasis	8.69e-05	0.000289	CcSEcCtD
Clonidine—Nervous system disorder—Betamethasone—psoriasis	8.69e-05	0.000289	CcSEcCtD
Clonidine—Agitation—Prednisone—psoriasis	8.69e-05	0.000289	CcSEcCtD
Clonidine—Thrombocytopenia—Betamethasone—psoriasis	8.68e-05	0.000288	CcSEcCtD
Clonidine—Thrombocytopenia—Dexamethasone—psoriasis	8.68e-05	0.000288	CcSEcCtD
Clonidine—Tachycardia—Dexamethasone—psoriasis	8.65e-05	0.000287	CcSEcCtD
Clonidine—Tachycardia—Betamethasone—psoriasis	8.65e-05	0.000287	CcSEcCtD
Clonidine—Angioedema—Prednisone—psoriasis	8.64e-05	0.000287	CcSEcCtD
Clonidine—Hypersensitivity—Cyclosporine—psoriasis	8.6e-05	0.000286	CcSEcCtD
Clonidine—Nausea—Mycophenolic acid—psoriasis	8.57e-05	0.000285	CcSEcCtD
Clonidine—Hyperhidrosis—Dexamethasone—psoriasis	8.57e-05	0.000284	CcSEcCtD
Clonidine—Hyperhidrosis—Betamethasone—psoriasis	8.57e-05	0.000284	CcSEcCtD
Clonidine—Feeling abnormal—Hydrocortisone—psoriasis	8.55e-05	0.000284	CcSEcCtD
Clonidine—Malaise—Prednisone—psoriasis	8.53e-05	0.000283	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—psoriasis	8.48e-05	0.000282	CcSEcCtD
Clonidine—Gastrointestinal pain—Hydrocortisone—psoriasis	8.48e-05	0.000282	CcSEcCtD
Clonidine—Syncope—Prednisone—psoriasis	8.48e-05	0.000282	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—psoriasis	8.46e-05	0.000281	CcSEcCtD
Clonidine—Anorexia—Dexamethasone—psoriasis	8.45e-05	0.000281	CcSEcCtD
Clonidine—Anorexia—Betamethasone—psoriasis	8.45e-05	0.000281	CcSEcCtD
Clonidine—Urticaria—Prednisolone—psoriasis	8.44e-05	0.00028	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—psoriasis	8.42e-05	0.00028	CcSEcCtD
Clonidine—Fatigue—Triamcinolone—psoriasis	8.42e-05	0.00028	CcSEcCtD
Clonidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.39e-05	0.000279	CcSEcCtD
Clonidine—Asthenia—Cyclosporine—psoriasis	8.37e-05	0.000278	CcSEcCtD
Clonidine—Pain—Triamcinolone—psoriasis	8.35e-05	0.000277	CcSEcCtD
Clonidine—Loss of consciousness—Prednisone—psoriasis	8.31e-05	0.000276	CcSEcCtD
Clonidine—Hypotension—Dexamethasone—psoriasis	8.28e-05	0.000275	CcSEcCtD
Clonidine—Hypotension—Betamethasone—psoriasis	8.28e-05	0.000275	CcSEcCtD
Clonidine—Pruritus—Cyclosporine—psoriasis	8.26e-05	0.000274	CcSEcCtD
Clonidine—Urticaria—Hydrocortisone—psoriasis	8.24e-05	0.000274	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—psoriasis	8.24e-05	0.000274	CcSEcCtD
Clonidine—Abdominal pain—Hydrocortisone—psoriasis	8.2e-05	0.000272	CcSEcCtD
Clonidine—Body temperature increased—Hydrocortisone—psoriasis	8.2e-05	0.000272	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—psoriasis	8.18e-05	0.000272	CcSEcCtD
Clonidine—Asthenia—Mycophenolate mofetil—psoriasis	8.17e-05	0.000271	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.07e-05	0.000268	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Betamethasone—psoriasis	8.07e-05	0.000268	CcSEcCtD
Clonidine—Pruritus—Mycophenolate mofetil—psoriasis	8.05e-05	0.000267	CcSEcCtD
Clonidine—Arthralgia—Prednisone—psoriasis	8.05e-05	0.000267	CcSEcCtD
Clonidine—Feeling abnormal—Triamcinolone—psoriasis	8.05e-05	0.000267	CcSEcCtD
Clonidine—Anxiety—Prednisone—psoriasis	8.02e-05	0.000266	CcSEcCtD
Clonidine—Alopecia—Methotrexate—psoriasis	8.02e-05	0.000266	CcSEcCtD
Clonidine—Insomnia—Dexamethasone—psoriasis	8.01e-05	0.000266	CcSEcCtD
Clonidine—Insomnia—Betamethasone—psoriasis	8.01e-05	0.000266	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.99e-05	0.000266	CcSEcCtD
Clonidine—Diarrhoea—Cyclosporine—psoriasis	7.98e-05	0.000265	CcSEcCtD
Clonidine—Paraesthesia—Betamethasone—psoriasis	7.96e-05	0.000264	CcSEcCtD
Clonidine—Paraesthesia—Dexamethasone—psoriasis	7.96e-05	0.000264	CcSEcCtD
Clonidine—Discomfort—Prednisone—psoriasis	7.95e-05	0.000264	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—psoriasis	7.95e-05	0.000264	CcSEcCtD
Clonidine—Erythema—Methotrexate—psoriasis	7.9e-05	0.000262	CcSEcCtD
Clonidine—Hypersensitivity—Prednisolone—psoriasis	7.82e-05	0.00026	CcSEcCtD
Clonidine—Diarrhoea—Mycophenolate mofetil—psoriasis	7.79e-05	0.000259	CcSEcCtD
Clonidine—Urticaria—Triamcinolone—psoriasis	7.76e-05	0.000258	CcSEcCtD
Clonidine—Body temperature increased—Triamcinolone—psoriasis	7.72e-05	0.000256	CcSEcCtD
Clonidine—Dizziness—Cyclosporine—psoriasis	7.72e-05	0.000256	CcSEcCtD
Clonidine—Oedema—Prednisone—psoriasis	7.72e-05	0.000256	CcSEcCtD
Clonidine—Decreased appetite—Betamethasone—psoriasis	7.7e-05	0.000256	CcSEcCtD
Clonidine—Decreased appetite—Dexamethasone—psoriasis	7.7e-05	0.000256	CcSEcCtD
Clonidine—Infection—Prednisone—psoriasis	7.67e-05	0.000255	CcSEcCtD
Clonidine—Gastrointestinal disorder—Betamethasone—psoriasis	7.65e-05	0.000254	CcSEcCtD
Clonidine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.65e-05	0.000254	CcSEcCtD
Clonidine—Hypersensitivity—Hydrocortisone—psoriasis	7.64e-05	0.000254	CcSEcCtD
Clonidine—Fatigue—Dexamethasone—psoriasis	7.64e-05	0.000254	CcSEcCtD
Clonidine—Fatigue—Betamethasone—psoriasis	7.64e-05	0.000254	CcSEcCtD
Clonidine—Shock—Prednisone—psoriasis	7.59e-05	0.000252	CcSEcCtD
Clonidine—Pain—Dexamethasone—psoriasis	7.58e-05	0.000252	CcSEcCtD
Clonidine—Pain—Betamethasone—psoriasis	7.58e-05	0.000252	CcSEcCtD
Clonidine—Nervous system disorder—Prednisone—psoriasis	7.57e-05	0.000251	CcSEcCtD
Clonidine—Tachycardia—Prednisone—psoriasis	7.53e-05	0.00025	CcSEcCtD
Clonidine—Dizziness—Mycophenolate mofetil—psoriasis	7.53e-05	0.00025	CcSEcCtD
Clonidine—Skin disorder—Prednisone—psoriasis	7.5e-05	0.000249	CcSEcCtD
Clonidine—Hyperhidrosis—Prednisone—psoriasis	7.46e-05	0.000248	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—psoriasis	7.45e-05	0.000247	CcSEcCtD
Clonidine—Asthenia—Hydrocortisone—psoriasis	7.44e-05	0.000247	CcSEcCtD
Clonidine—Vomiting—Cyclosporine—psoriasis	7.42e-05	0.000246	CcSEcCtD
Clonidine—Rash—Cyclosporine—psoriasis	7.36e-05	0.000244	CcSEcCtD
Clonidine—Anorexia—Prednisone—psoriasis	7.36e-05	0.000244	CcSEcCtD
Clonidine—Dermatitis—Cyclosporine—psoriasis	7.35e-05	0.000244	CcSEcCtD
Clonidine—Pruritus—Hydrocortisone—psoriasis	7.34e-05	0.000244	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—psoriasis	7.33e-05	0.000243	CcSEcCtD
Clonidine—Headache—Cyclosporine—psoriasis	7.31e-05	0.000243	CcSEcCtD
Clonidine—Feeling abnormal—Dexamethasone—psoriasis	7.3e-05	0.000243	CcSEcCtD
Clonidine—Feeling abnormal—Betamethasone—psoriasis	7.3e-05	0.000243	CcSEcCtD
Clonidine—Gastrointestinal pain—Betamethasone—psoriasis	7.25e-05	0.000241	CcSEcCtD
Clonidine—Gastrointestinal pain—Dexamethasone—psoriasis	7.25e-05	0.000241	CcSEcCtD
Clonidine—Vomiting—Mycophenolate mofetil—psoriasis	7.24e-05	0.00024	CcSEcCtD
Clonidine—Hypersensitivity—Triamcinolone—psoriasis	7.19e-05	0.000239	CcSEcCtD
Clonidine—Rash—Mycophenolate mofetil—psoriasis	7.18e-05	0.000238	CcSEcCtD
Clonidine—Dermatitis—Mycophenolate mofetil—psoriasis	7.17e-05	0.000238	CcSEcCtD
Clonidine—Headache—Mycophenolate mofetil—psoriasis	7.13e-05	0.000237	CcSEcCtD
Clonidine—Malaise—Methotrexate—psoriasis	7.13e-05	0.000237	CcSEcCtD
Clonidine—Diarrhoea—Hydrocortisone—psoriasis	7.1e-05	0.000236	CcSEcCtD
Clonidine—Urticaria—Betamethasone—psoriasis	7.04e-05	0.000234	CcSEcCtD
Clonidine—Urticaria—Dexamethasone—psoriasis	7.04e-05	0.000234	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Prednisone—psoriasis	7.03e-05	0.000233	CcSEcCtD
Clonidine—Dizziness—Prednisolone—psoriasis	7.02e-05	0.000233	CcSEcCtD
Clonidine—Asthenia—Triamcinolone—psoriasis	7.01e-05	0.000233	CcSEcCtD
Clonidine—Abdominal pain—Betamethasone—psoriasis	7e-05	0.000233	CcSEcCtD
Clonidine—Abdominal pain—Dexamethasone—psoriasis	7e-05	0.000233	CcSEcCtD
Clonidine—Body temperature increased—Dexamethasone—psoriasis	7e-05	0.000233	CcSEcCtD
Clonidine—Body temperature increased—Betamethasone—psoriasis	7e-05	0.000233	CcSEcCtD
Clonidine—Insomnia—Prednisone—psoriasis	6.98e-05	0.000232	CcSEcCtD
Clonidine—Nausea—Cyclosporine—psoriasis	6.93e-05	0.00023	CcSEcCtD
Clonidine—Paraesthesia—Prednisone—psoriasis	6.93e-05	0.00023	CcSEcCtD
Clonidine—Pruritus—Triamcinolone—psoriasis	6.91e-05	0.000229	CcSEcCtD
Clonidine—Cough—Methotrexate—psoriasis	6.9e-05	0.000229	CcSEcCtD
Clonidine—Dizziness—Hydrocortisone—psoriasis	6.86e-05	0.000228	CcSEcCtD
Clonidine—Nausea—Mycophenolate mofetil—psoriasis	6.76e-05	0.000225	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—psoriasis	6.73e-05	0.000223	CcSEcCtD
Clonidine—Chest pain—Methotrexate—psoriasis	6.73e-05	0.000223	CcSEcCtD
Clonidine—Decreased appetite—Prednisone—psoriasis	6.71e-05	0.000223	CcSEcCtD
Clonidine—Rash—Prednisolone—psoriasis	6.7e-05	0.000222	CcSEcCtD
Clonidine—Dermatitis—Prednisolone—psoriasis	6.69e-05	0.000222	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.68e-05	0.000222	CcSEcCtD
Clonidine—Fatigue—Prednisone—psoriasis	6.65e-05	0.000221	CcSEcCtD
Clonidine—Headache—Prednisolone—psoriasis	6.65e-05	0.000221	CcSEcCtD
Clonidine—Discomfort—Methotrexate—psoriasis	6.65e-05	0.000221	CcSEcCtD
Clonidine—Constipation—Prednisone—psoriasis	6.6e-05	0.000219	CcSEcCtD
Clonidine—Vomiting—Hydrocortisone—psoriasis	6.59e-05	0.000219	CcSEcCtD
Clonidine—Rash—Hydrocortisone—psoriasis	6.54e-05	0.000217	CcSEcCtD
Clonidine—Dermatitis—Hydrocortisone—psoriasis	6.53e-05	0.000217	CcSEcCtD
Clonidine—Confusional state—Methotrexate—psoriasis	6.5e-05	0.000216	CcSEcCtD
Clonidine—Headache—Hydrocortisone—psoriasis	6.5e-05	0.000216	CcSEcCtD
Clonidine—Dizziness—Triamcinolone—psoriasis	6.46e-05	0.000214	CcSEcCtD
Clonidine—Infection—Methotrexate—psoriasis	6.41e-05	0.000213	CcSEcCtD
Clonidine—Feeling abnormal—Prednisone—psoriasis	6.36e-05	0.000211	CcSEcCtD
Clonidine—Asthenia—Betamethasone—psoriasis	6.36e-05	0.000211	CcSEcCtD
Clonidine—Asthenia—Dexamethasone—psoriasis	6.36e-05	0.000211	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—psoriasis	6.32e-05	0.00021	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—psoriasis	6.31e-05	0.00021	CcSEcCtD
Clonidine—Gastrointestinal pain—Prednisone—psoriasis	6.31e-05	0.00021	CcSEcCtD
Clonidine—Nausea—Prednisolone—psoriasis	6.31e-05	0.000209	CcSEcCtD
Clonidine—Pruritus—Dexamethasone—psoriasis	6.27e-05	0.000208	CcSEcCtD
Clonidine—Pruritus—Betamethasone—psoriasis	6.27e-05	0.000208	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—psoriasis	6.26e-05	0.000208	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—psoriasis	6.23e-05	0.000207	CcSEcCtD
Clonidine—Vomiting—Triamcinolone—psoriasis	6.21e-05	0.000206	CcSEcCtD
Clonidine—Nausea—Hydrocortisone—psoriasis	6.16e-05	0.000205	CcSEcCtD
Clonidine—Rash—Triamcinolone—psoriasis	6.16e-05	0.000204	CcSEcCtD
Clonidine—Dermatitis—Triamcinolone—psoriasis	6.15e-05	0.000204	CcSEcCtD
Clonidine—Anorexia—Methotrexate—psoriasis	6.15e-05	0.000204	CcSEcCtD
Clonidine—Urticaria—Prednisone—psoriasis	6.13e-05	0.000204	CcSEcCtD
Clonidine—Headache—Triamcinolone—psoriasis	6.12e-05	0.000203	CcSEcCtD
Clonidine—Abdominal pain—Prednisone—psoriasis	6.1e-05	0.000203	CcSEcCtD
Clonidine—Body temperature increased—Prednisone—psoriasis	6.1e-05	0.000203	CcSEcCtD
Clonidine—Diarrhoea—Betamethasone—psoriasis	6.06e-05	0.000201	CcSEcCtD
Clonidine—Diarrhoea—Dexamethasone—psoriasis	6.06e-05	0.000201	CcSEcCtD
Clonidine—Hypotension—Methotrexate—psoriasis	6.03e-05	0.0002	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—psoriasis	5.88e-05	0.000195	CcSEcCtD
Clonidine—Dizziness—Betamethasone—psoriasis	5.86e-05	0.000195	CcSEcCtD
Clonidine—Dizziness—Dexamethasone—psoriasis	5.86e-05	0.000195	CcSEcCtD
Clonidine—Insomnia—Methotrexate—psoriasis	5.83e-05	0.000194	CcSEcCtD
Clonidine—Nausea—Triamcinolone—psoriasis	5.8e-05	0.000193	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—psoriasis	5.79e-05	0.000192	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—psoriasis	5.75e-05	0.000191	CcSEcCtD
Clonidine—Somnolence—Methotrexate—psoriasis	5.73e-05	0.00019	CcSEcCtD
Clonidine—Hypersensitivity—Prednisone—psoriasis	5.69e-05	0.000189	CcSEcCtD
Clonidine—Vomiting—Dexamethasone—psoriasis	5.63e-05	0.000187	CcSEcCtD
Clonidine—Vomiting—Betamethasone—psoriasis	5.63e-05	0.000187	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—psoriasis	5.61e-05	0.000186	CcSEcCtD
Clonidine—Rash—Betamethasone—psoriasis	5.59e-05	0.000186	CcSEcCtD
Clonidine—Rash—Dexamethasone—psoriasis	5.59e-05	0.000186	CcSEcCtD
Clonidine—Dermatitis—Betamethasone—psoriasis	5.58e-05	0.000185	CcSEcCtD
Clonidine—Dermatitis—Dexamethasone—psoriasis	5.58e-05	0.000185	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—psoriasis	5.57e-05	0.000185	CcSEcCtD
Clonidine—Fatigue—Methotrexate—psoriasis	5.56e-05	0.000185	CcSEcCtD
Clonidine—Headache—Dexamethasone—psoriasis	5.55e-05	0.000184	CcSEcCtD
Clonidine—Headache—Betamethasone—psoriasis	5.55e-05	0.000184	CcSEcCtD
Clonidine—Asthenia—Prednisone—psoriasis	5.54e-05	0.000184	CcSEcCtD
Clonidine—Pain—Methotrexate—psoriasis	5.51e-05	0.000183	CcSEcCtD
Clonidine—Pruritus—Prednisone—psoriasis	5.46e-05	0.000181	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—psoriasis	5.31e-05	0.000176	CcSEcCtD
Clonidine—Diarrhoea—Prednisone—psoriasis	5.28e-05	0.000175	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—psoriasis	5.27e-05	0.000175	CcSEcCtD
Clonidine—Nausea—Dexamethasone—psoriasis	5.26e-05	0.000175	CcSEcCtD
Clonidine—Nausea—Betamethasone—psoriasis	5.26e-05	0.000175	CcSEcCtD
Clonidine—Urticaria—Methotrexate—psoriasis	5.12e-05	0.00017	CcSEcCtD
Clonidine—Dizziness—Prednisone—psoriasis	5.1e-05	0.000169	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—psoriasis	5.1e-05	0.000169	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—psoriasis	5.1e-05	0.000169	CcSEcCtD
Clonidine—Vomiting—Prednisone—psoriasis	4.91e-05	0.000163	CcSEcCtD
Clonidine—Rash—Prednisone—psoriasis	4.87e-05	0.000162	CcSEcCtD
Clonidine—Dermatitis—Prednisone—psoriasis	4.86e-05	0.000161	CcSEcCtD
Clonidine—Headache—Prednisone—psoriasis	4.83e-05	0.000161	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—psoriasis	4.75e-05	0.000158	CcSEcCtD
Clonidine—Asthenia—Methotrexate—psoriasis	4.63e-05	0.000154	CcSEcCtD
Clonidine—Nausea—Prednisone—psoriasis	4.58e-05	0.000152	CcSEcCtD
Clonidine—Pruritus—Methotrexate—psoriasis	4.56e-05	0.000152	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—psoriasis	4.41e-05	0.000147	CcSEcCtD
Clonidine—Dizziness—Methotrexate—psoriasis	4.26e-05	0.000142	CcSEcCtD
Clonidine—Vomiting—Methotrexate—psoriasis	4.1e-05	0.000136	CcSEcCtD
Clonidine—Rash—Methotrexate—psoriasis	4.07e-05	0.000135	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—psoriasis	4.06e-05	0.000135	CcSEcCtD
Clonidine—Headache—Methotrexate—psoriasis	4.04e-05	0.000134	CcSEcCtD
Clonidine—Nausea—Methotrexate—psoriasis	3.83e-05	0.000127	CcSEcCtD
Clonidine—ADRA2C—Metabolism—NDUFA5—psoriasis	3.12e-05	0.00156	CbGpPWpGaD
Clonidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	3.1e-05	0.00155	CbGpPWpGaD
Clonidine—ADRA1B—AMPK Signaling—TP53—psoriasis	3.02e-05	0.00151	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—NDUFA5—psoriasis	2.99e-05	0.0015	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HCAR2—psoriasis	2.91e-05	0.00146	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.88e-05	0.00144	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—ITGAL—psoriasis	2.81e-05	0.00141	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—CCL20—psoriasis	2.81e-05	0.00141	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	2.78e-05	0.00139	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.77e-05	0.00139	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.74e-05	0.00137	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—IFNG—psoriasis	2.71e-05	0.00136	CbGpPWpGaD
Clonidine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.7e-05	0.00135	CbGpPWpGaD
Clonidine—ADRA1A—AMPK Signaling—TP53—psoriasis	2.68e-05	0.00134	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CYP2S1—psoriasis	2.65e-05	0.00133	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	2.65e-05	0.00133	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HCAR2—psoriasis	2.62e-05	0.00131	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—CCL20—psoriasis	2.56e-05	0.00128	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—CCL20—psoriasis	2.54e-05	0.00127	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CYP2S1—psoriasis	2.54e-05	0.00127	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NDUFA5—psoriasis	2.53e-05	0.00127	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TAGAP—psoriasis	2.52e-05	0.00126	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.52e-05	0.00126	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.51e-05	0.00126	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HCAR2—psoriasis	2.45e-05	0.00123	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HCAR2—psoriasis	2.41e-05	0.00121	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—CCL20—psoriasis	2.37e-05	0.00119	CbGpPWpGaD
Clonidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.36e-05	0.00118	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—CCL20—psoriasis	2.34e-05	0.00117	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NDUFA5—psoriasis	2.32e-05	0.00116	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—CCL20—psoriasis	2.31e-05	0.00116	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TAGAP—psoriasis	2.27e-05	0.00114	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.27e-05	0.00114	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NDUFA5—psoriasis	2.19e-05	0.0011	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.16e-05	0.00108	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.16e-05	0.00108	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—CCL20—psoriasis	2.16e-05	0.00108	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CYP2S1—psoriasis	2.15e-05	0.00108	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HCAR2—psoriasis	2.14e-05	0.00107	CbGpPWpGaD
Clonidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.14e-05	0.00107	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TAGAP—psoriasis	2.13e-05	0.00106	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CARM1—psoriasis	2.12e-05	0.00106	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—CCL20—psoriasis	2.12e-05	0.00106	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TAGAP—psoriasis	2.09e-05	0.00105	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—CCL20—psoriasis	2.07e-05	0.00104	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.07e-05	0.00104	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.04e-05	0.00102	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.04e-05	0.00102	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.02e-05	0.00101	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—CXCL8—psoriasis	2.01e-05	0.001	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HCAR2—psoriasis	1.99e-05	0.000997	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CYP2S1—psoriasis	1.97e-05	0.000989	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—CCL20—psoriasis	1.93e-05	0.000966	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CCL20—psoriasis	1.88e-05	0.000944	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—CXCL8—psoriasis	1.87e-05	0.000938	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CYP2S1—psoriasis	1.86e-05	0.000934	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TAGAP—psoriasis	1.86e-05	0.000931	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.77e-05	0.000885	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—TNF—psoriasis	1.75e-05	0.000878	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NDUFA5—psoriasis	1.75e-05	0.000877	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CCL20—psoriasis	1.75e-05	0.000877	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.74e-05	0.000872	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TAGAP—psoriasis	1.73e-05	0.000865	CbGpPWpGaD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.71e-05	0.000857	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NDUFA5—psoriasis	1.65e-05	0.000827	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.63e-05	0.000815	CbGpPWpGaD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.6e-05	0.000801	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.59e-05	0.000799	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.55e-05	0.000778	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—NOS2—psoriasis	1.52e-05	0.000763	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	1.52e-05	0.000762	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCL20—psoriasis	1.51e-05	0.000756	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.49e-05	0.000746	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CYP2S1—psoriasis	1.49e-05	0.000746	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.47e-05	0.000734	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—NOS2—psoriasis	1.42e-05	0.000712	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.4e-05	0.000703	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.4e-05	0.0007	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCL20—psoriasis	1.36e-05	0.000683	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—CXCL8—psoriasis	1.34e-05	0.000674	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.34e-05	0.000671	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CAT—psoriasis	1.31e-05	0.000654	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.3e-05	0.000653	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.3e-05	0.000652	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.3e-05	0.00065	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CARM1—psoriasis	1.29e-05	0.000649	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCL20—psoriasis	1.27e-05	0.000638	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCL20—psoriasis	1.25e-05	0.000628	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CARM1—psoriasis	1.24e-05	0.000622	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—CXCL8—psoriasis	1.21e-05	0.000608	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.21e-05	0.000606	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP2S1—psoriasis	1.19e-05	0.000596	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—NOS2—psoriasis	1.15e-05	0.000579	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.15e-05	0.000578	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—CXCL8—psoriasis	1.13e-05	0.000568	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—CXCL8—psoriasis	1.12e-05	0.000559	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL20—psoriasis	1.11e-05	0.000558	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.11e-05	0.000557	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.11e-05	0.000557	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.08e-05	0.000541	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CARM1—psoriasis	1.05e-05	0.000527	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL20—psoriasis	1.03e-05	0.000518	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—APOE—psoriasis	1.01e-05	0.000508	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.01e-05	0.000505	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	9.91e-06	0.000497	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	9.88e-06	0.000495	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.77e-06	0.000489	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CARM1—psoriasis	9.64e-06	0.000483	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	9.21e-06	0.000461	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2S1—psoriasis	9.17e-06	0.00046	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CARM1—psoriasis	9.1e-06	0.000456	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PPARG—psoriasis	8.83e-06	0.000443	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—VEGFA—psoriasis	8.82e-06	0.000442	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.64e-06	0.000433	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.51e-06	0.000426	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SOCS1—psoriasis	8.31e-06	0.000416	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—VEGFA—psoriasis	8.24e-06	0.000413	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CAT—psoriasis	7.96e-06	0.000399	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—TYK2—psoriasis	7.93e-06	0.000397	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CAT—psoriasis	7.63e-06	0.000382	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.62e-06	0.000382	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—CXCL8—psoriasis	7.6e-06	0.000381	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SOCS1—psoriasis	7.5e-06	0.000376	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CARM1—psoriasis	7.27e-06	0.000364	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—TYK2—psoriasis	7.16e-06	0.000359	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SOCS1—psoriasis	7.01e-06	0.000351	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	6.9e-06	0.000346	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	6.9e-06	0.000346	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—CXCL8—psoriasis	6.86e-06	0.000344	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CARM1—psoriasis	6.85e-06	0.000343	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—VEGFA—psoriasis	6.69e-06	0.000335	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—TYK2—psoriasis	6.68e-06	0.000335	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—psoriasis	6.66e-06	0.000334	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	6.58e-06	0.00033	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CAT—psoriasis	6.47e-06	0.000324	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	6.41e-06	0.000321	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	6.31e-06	0.000316	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—CXCL8—psoriasis	6.23e-06	0.000312	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.23e-06	0.000312	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—psoriasis	6.22e-06	0.000312	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—APOE—psoriasis	6.19e-06	0.00031	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—LEP—psoriasis	6.13e-06	0.000307	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—APOE—psoriasis	6.13e-06	0.000307	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	6.13e-06	0.000307	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—APOE—psoriasis	5.93e-06	0.000297	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CAT—psoriasis	5.93e-06	0.000297	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	5.84e-06	0.000293	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	5.82e-06	0.000292	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CARM1—psoriasis	5.8e-06	0.000291	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	5.73e-06	0.000287	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	5.72e-06	0.000286	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	5.69e-06	0.000285	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	5.6e-06	0.000281	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CAT—psoriasis	5.6e-06	0.000281	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—APOE—psoriasis	5.54e-06	0.000277	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—LEP—psoriasis	5.54e-06	0.000277	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	5.43e-06	0.000272	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.43e-06	0.000272	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PPARG—psoriasis	5.39e-06	0.00027	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	5.21e-06	0.000261	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—LEP—psoriasis	5.17e-06	0.000259	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—APOE—psoriasis	5.17e-06	0.000259	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PPARG—psoriasis	5.16e-06	0.000259	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	5.16e-06	0.000259	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—LEP—psoriasis	5.09e-06	0.000255	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—APOE—psoriasis	5.09e-06	0.000255	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	5.09e-06	0.000255	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—psoriasis	5.05e-06	0.000253	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—APOE—psoriasis	5.03e-06	0.000252	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	4.82e-06	0.000242	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	4.74e-06	0.000238	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	4.73e-06	0.000237	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TYK2—psoriasis	4.68e-06	0.000235	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—APOE—psoriasis	4.61e-06	0.000231	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—LEP—psoriasis	4.52e-06	0.000227	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APOE—psoriasis	4.52e-06	0.000227	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CARM1—psoriasis	4.48e-06	0.000224	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CAT—psoriasis	4.47e-06	0.000224	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PPARG—psoriasis	4.38e-06	0.000219	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—APOE—psoriasis	4.35e-06	0.000218	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TYK2—psoriasis	4.23e-06	0.000212	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAT—psoriasis	4.21e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	4.21e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—LEP—psoriasis	4.2e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOE—psoriasis	4.2e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	4.08e-06	0.000204	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—psoriasis	4.01e-06	0.000201	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TYK2—psoriasis	3.95e-06	0.000198	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	3.92e-06	0.000196	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TYK2—psoriasis	3.89e-06	0.000195	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—psoriasis	3.88e-06	0.000194	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—JUN—psoriasis	3.79e-06	0.00019	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—psoriasis	3.79e-06	0.00019	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—psoriasis	3.68e-06	0.000184	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	3.65e-06	0.000183	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAT—psoriasis	3.57e-06	0.000179	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—psoriasis	3.5e-06	0.000175	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOE—psoriasis	3.47e-06	0.000174	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TYK2—psoriasis	3.45e-06	0.000173	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	3.44e-06	0.000172	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—JUN—psoriasis	3.42e-06	0.000171	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	3.38e-06	0.00017	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	3.31e-06	0.000166	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NFKB1—psoriasis	3.29e-06	0.000165	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—psoriasis	3.28e-06	0.000164	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOE—psoriasis	3.27e-06	0.000164	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—psoriasis	3.27e-06	0.000164	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—psoriasis	3.22e-06	0.000161	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TYK2—psoriasis	3.21e-06	0.000161	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—JUN—psoriasis	3.2e-06	0.00016	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—JUN—psoriasis	3.15e-06	0.000158	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	3.08e-06	0.000154	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	3.03e-06	0.000152	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—psoriasis	3.03e-06	0.000152	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	3.01e-06	0.000151	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—psoriasis	2.99e-06	0.00015	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—psoriasis	2.96e-06	0.000148	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—psoriasis	2.86e-06	0.000143	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—psoriasis	2.85e-06	0.000143	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JUN—psoriasis	2.79e-06	0.00014	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	2.79e-06	0.00014	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	2.79e-06	0.00014	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOE—psoriasis	2.77e-06	0.000139	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—psoriasis	2.76e-06	0.000139	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAT—psoriasis	2.76e-06	0.000138	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	2.75e-06	0.000138	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—psoriasis	2.72e-06	0.000136	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	2.69e-06	0.000135	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—psoriasis	2.66e-06	0.000133	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JUN—psoriasis	2.6e-06	0.00013	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—psoriasis	2.5e-06	0.000125	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	2.5e-06	0.000125	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	2.44e-06	0.000122	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—psoriasis	2.42e-06	0.000121	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—psoriasis	2.42e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—psoriasis	2.29e-06	0.000115	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	2.27e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—psoriasis	2.26e-06	0.000113	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—psoriasis	2.25e-06	0.000113	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOE—psoriasis	2.14e-06	0.000107	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—psoriasis	2.11e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—psoriasis	2.08e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—psoriasis	2.07e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—psoriasis	1.93e-06	9.68e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—psoriasis	1.9e-06	9.52e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—psoriasis	1.86e-06	9.34e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—psoriasis	1.84e-06	9.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—psoriasis	1.71e-06	8.59e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—psoriasis	1.69e-06	8.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—psoriasis	1.57e-06	7.86e-05	CbGpPWpGaD
